Clinical trial
Evaluation of the Circulating Concentration of Olfactomédine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging
NCT02653105 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Circulating Concentration of Olfactomédine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging
- Lead sponsor
- Institut Cancerologie de l'Ouest
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 8, 2016
- Completion date
- March 31, 2026
- Enrollment
- 150 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.